Phasic and sustained fear are pharmacologically dissociable in rats

Neuropsychopharmacology

Volumn 36, Issue 8, 2011, Pages 1563-1574

  Miles, Leigh ^a   Davis, Michael ^b   Walker, David ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bed nucleus stria terminalis; benzodiazepine; buspirone; fluoxetine; SSRIs; startle

Indexed keywords

BUSPIRONE; CHLORDIAZEPOXIDE; FLUOXETINE;

ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEAR; FOOTSHOCK; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; BUSPIRONE; CHLORDIAZEPOXIDE; CONDITIONING (PSYCHOLOGY); FEAR; HUMANS; MALE; MODELS, PSYCHOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; TIME FACTORS;

EID: 79958804853     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.29     Document Type: Article

References (71)

1. Arluison M, Brochier G, Vankova M, Leviel V, Villalobos J, Tramu G (1994). Demonstration of peptidergic afferents to the bed nucleus of the stria terminalis using local injections of colchicine. A combined immunohistochemical and retrograde tracing study. Brain Res Bull 34: 319-337. (Pubitemid 24156798)
2. Baas JM, Grillon C, Bocker KB, Brack AA, Morgan III CA, Kenemans JL et al (2002). Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology (Berl) 161: 233-247. (Pubitemid 34591661)
3. Bitsios P, Philpott A, Langley RW, Bradshaw CM, Szabadi E (1999). Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man. J Psychopharmacol 13: 226-234. (Pubitemid 29435781)
4. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE (2004). The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55: 1171-1178. (Pubitemid 38739451)
5. Cassell MD, Gray TS, Kiss JZ (1986). Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J Comp Neurol 246: 478-499. (Pubitemid 16079511)
6. Chalmers DT, Lovenberg TW, De Souza EB (1995). Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340-6350.
7. Christopoulos G, Paxinos G, Huang XF, Beaumont K, Toga AW, Sexton PM (1995). Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol 73: 1037-1041.
8. Commissaris RL, Davis M (1982). Opposite effects of N,N- dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltrypta-mine (5-MeODMT) on acoustic startle: spinal vs brain sites of action. Neurosci Biobehav Rev 6: 515-520. (Pubitemid 13170725)
9. Davis M (1979). Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology (Berl) 62: 1-7. (Pubitemid 10226227)
10. Davis M (1986). Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav Neurosci 100: 814-824. (Pubitemid 17002689)
11. Davis M (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61: 741-756. (Pubitemid 44789942)
12. Davis M, Astrachan DI, Gendelman PM, Gendelman DS (1980a). 5-Methoxy-N,N-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle. Psychophar-macology (Berl) 70: 123-130. (Pubitemid 10008769)
13. Davis M, Cassella JV, Kehne JH (1988). Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psy-chopharmacology (Berl) 94: 14-20. (Pubitemid 18009057)
14. Davis M, Strachan DI, Kass E (1980b). Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle. Science 209: 521-23. (Pubitemid 10022764)
15. Davis M, Walker DL, Miles L, Grillon C (2010). Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35: 105-135.
16. Freedman LJ, Shi C (2001). Monoaminergic innervation of the macaque extended amygdala. Neuroscience 104: 1067-1084. (Pubitemid 32701967)
17. Gewirtz JC, McNish KA, Davis M (1998). Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Prog Neuropsychopharmacol Biol Psychiatry 22: 625-648. (Pubitemid 28281227)
18. Goa KL, Ward A (1986). Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32: 114-129. (Pubitemid 16072093)
19. Goodman WK (2004). Selecting pharmacotherapy for generalized anxiety disorder. J Clin Psychiatry 65(Suppl 13): 8-13.
20. Graham SJ, Scaife JC, Langley RW, Bradshaw CM, Szabadi E, Xi L et al (2005). Effects of lorazepam on fear-potentiated startle responses in man. J Psychopharmacol 19: 249-258. (Pubitemid 40694943)
21. Gray TS, Magnuson DJ (1992). Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13: 451-460.
22. Grillon C, Baas JM (2002). Comments on the use of the startle reflex in psychopharmacological challenges: impact of baseline startle on measurement of fear-potentiated startle. Psychophar-macology (Berl) 164: 236-238. (Pubitemid 36015590)
23. Grillon C, Baas JM, Pine DS, Lissek S, Lawley M, Ellis V et al (2006). The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry 60: 760-766. (Pubitemid 44427760)
24. Grillon C, Chavis C, Covington MF, Pine DS (2009a). Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study. Neuropsy-chopharmacology 34: 964-971.
25. Grillon C, Lissek S, Rabin S, McDowell D, Dvir S, Pine DS (2008). Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry 165: 898-904. (Pubitemid 351948722)
26. Grillon C, Pine DS, Lissek S, Rabin S, Bonne O, Vythilingam M (2009b). Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol Psychiatry 66: 47-53.
27. Guscott MR, Cook GP, Bristow LJ (2000). Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists. Behav Pharmacol 11: 495-504.
28. Hammack SE, Guo JD, Hazra R, Dabrowska J, Myers KM, Rainnie DG (2009). The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog Neuropsychopharmacol Biol Psychiatry 33: 1309-1320.
29. Hammack SE, Richey KJ, Watkins LR, Maier SF (2004). Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neu-rosci 118: 443-448. (Pubitemid 38445623)
30. Hitchcock JM, Davis M (1991). Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci 105: 826-842.
31. Jacobson AF, Dominguez RA, Goldstein BJ, Steinbook RM (1985). Comparison of buspirone and diazepam in generalized anxiety disorder. Pharmacotherapy 5: 290-296. (Pubitemid 16223223)
32. Ju G, Swanson LW, Simerly RB (1989). Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J Comp Neurol 280: 603-621. (Pubitemid 19069429)
33. Keene ON (1995). The log transformation is special. Stat Med 14: 811-819.
34. Kehne JH, Cassella JV, Davis M (1988). Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology (Berl) 94: 8-13. (Pubitemid 18009056)
35. Klumpers F, Raemaekers MA, Ruigrok AN, Hermans EJ, Kenemans JL, Baas JM (2010). Prefrontal mechanisms of fear reduction after threat offset. Biol Psychiatry 68: 1031-1038.
36. Kruger L, Mantyh PW, Sternini C, Brecha NC, Mantyh CR (1988). Calcitonin gene-related peptide (CGRP) in the rat central nervous system: patterns of immunoreactivity and receptor binding sites. Brain Res 463: 223-244.
37. Lee Y, Davis M (1997). Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17: 6434-6446. (Pubitemid 27329915)
38. Li XB, Inoue T, Hashimoto S, Koyama T (2001). Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur J Pharmacol 425: 43-50. (Pubitemid 32728298)
39. Liang KC, Melia KR, Campeau S, Falls WA, Miserendino MJ, Davis M (1992). Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex. J Neurosci 12: 2313-2320.
40. Mansbach RS, Geyer MA (1988). Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands. Eur J Pharmacol 156: 375-383. (Pubitemid 18262831)
41. McNish KA, Gewirtz JC, Davis M (1997). Evidence of contextual fear after lesions of the hippocampus: a disruption of freezing but not fear-potentiated startle. J Neurosci 17: 9353-9360. (Pubitemid 27498461)
42. Melia KR, Davis M (1991). Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam. Physiol Behav 49: 603-611.
43. Meloni EG, Davis M (1999). Muscimol in the deep layers of the superior colliculus/mesencephalic reticular formation blocks expression but not acquisition of fear-potentiated startle in rats. Behav Neurosci 113: 1152-1160. (Pubitemid 30013823)
44. Oler JA, Fox AS, Shelton SE, Christian BT, Murali D, Oakes TR et al (2009). Serotonin transporter availability in the amygdala and bed nucleus of the stria terminalis predicts anxious temperament and brain glucose metabolic activity. J Neurosci 29: 9961-9966.
45. Patrick CJ, Berthot BD, Moore JD (1996). Diazepam blocks fear-potentiated startle in humans. J Abnorm Psychol 105: 89-96. (Pubitemid 26039294)
46. Phelix CF, Liposits Z, Paull WK (1992). Serotonin-CRF interaction in the bed nucleus of the stria terminalis: a light microscopic double-label immunocytochemical analysis. Brain Res Bull 28: 943-948.
47. Phelps EA, O'Connor KJ, Gatenby JC, Gore JC, Grillon C, Davis M (2001). Activation of the left amygdala to a cognitive representation of fear. Nat Neurosci 4: 437-441. (Pubitemid 32260122)
48. Quinn JJ, Oommen SS, Morrison GE, Fanselow MS (2002). Post-training excitotoxic lesions of the dorsal hippocampus attenuate forward trace, backward trace, and delay fear conditioning in a temporally specific manner. Hippocampus 12: 495-504.
49. Quirk GJ, Repa C, LeDoux JE (1995). Fear conditioning enhances short-latency auditory responses of lateral amygdala neurons: parallel recordings in the freely behaving rat. Neuron 15: 1029-1039.
50. Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Barbanoj MJ (2001). Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose- response study. Psychopharmacology (Berl) 157: 358-367. (Pubitemid 32988482)
51. Roberts GW, Woodhams PL, Polak JM, Crow TJ (1982). Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience 7: 99-131. (Pubitemid 12212216)
52. Rosen JB, Hitchcock JM, Sananes CB, Miserendino MJ, Davis M (1991). A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies. Behav Neurosci 105: 817-825.
53. Santos JM, Martinez RC, Brandao ML (2006). Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning. Eur J Pharmacol 542: 121-128. (Pubitemid 44066375)
54. Scaife JC, Langley RW, Bradshaw CM, Szabadi E (2005). Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man. J Psychopharmacol 19: 347-356. (Pubitemid 41003130)
55. Shimada S, Inagaki S, Kubota Y, Ogawa N, Shibasaki T, Takagi H (1989). Coexistence of peptides (corticotropin releasing factor/ neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Neuroscience 30: 377-383. (Pubitemid 19168489)
56. Sink KS, Walker DL, Yang Y, Davis M (2011). Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J Neurosci 31: 1802-1810.
57. 125I calcitonin gene-related peptide binding sites in the rat central nervous system. Peptides 6: 975-986. (Pubitemid 16170989)
58. 3H]citalopram binding sites in the nonhuman primate brain. Ann NY Acad Sci 877: 700-702. (Pubitemid 29351895)
59. Somerville LH, Whalen PJ, Kelley WM (2010). Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biol Psychiatry 68: 416-424.
60. Sullivan GM, Apergis J, Bush DE, Johnson LR, Hou M, Ledoux JE (2004). Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128: 7-14. (Pubitemid 39140675)
61. Waddell J, Morris RW, Bouton ME (2006). Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci 120: 324-336. (Pubitemid 43807382)
62. Walker D, Yang Y, Ratti E, Corsi M, Trist D, Davis M (2009a). Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsy-chopharmacology 34: 1533-1542.
63. Walker DL, Davis M (1997a). Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry 42: 461-471. (Pubitemid 27394615)
64. Walker DL, Davis M (1997b). Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned vs unconditioned fear. J Neurosci 17: 9375-9383. (Pubitemid 27498464)
65. Walker DL, Davis M (2002a). Light-enhanced startle: further pharmacological and behavioral characterization. Psychophar-macology (Berl) 159: 304-310. (Pubitemid 34143379)
66. Walker DL, Davis M (2002b). Quantifying fear potentiated startle using absolute vs proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) 164: 318-328. (Pubitemid 35340999)
67. Walker DL, Miles LA, Davis M (2009b). Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like vs phasic fear-like responses. Prog Neuropsycho-pharmacol Biol Psychiatry 33: 1291-1308.
68. Walter A, Mai JK, Lanta L, Gorcs T (1991). Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat 4: 281-298.
69. Winslow JT, Noble PL, Davis M (2007). Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. Biol Psychiatry 61: 389-395. (Pubitemid 46108681)
70. Woodhams PL, Roberts GW, Polak JM, Crow TJ (1983). Distribution of neuropeptides in the limbic system of the rat: the bed nucleus of the stria terminalis, septum and preoptic area. Neuroscience 8: 677-703. (Pubitemid 13122676)
71. Zhao Z, Davis M (2004). Fear-potentiated startle in rats is mediated by neurons in the deep layers of the superior colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-NMDA receptors. J Neurosci 24: 10326-10334. (Pubitemid 39552616)